Health1 month ago
Pfizer Secures $495M Licensing Deal for Obesity Drug in China
Pfizer Inc. has announced a significant licensing agreement with China’s Sciwind Biosciences, focusing on its type 2 diabetes treatment known as ecnoglutide. The deal, valued at...
